Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma

Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma

书目详细资料
Main Authors:	Shrimanker, R, Pavord, I, Price, R, Bradford, E, Keene, O, Yancey, S
格式:	Conference item
出版:	American Thoracic Society 2018

相似书籍

Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide and their combination in severe asthma: a post-hoc analysis
由: Shrimanker, R, et al.
出版: (2019)

Evaluation of potential continuation rules for mepolizumab treatment of severe eosinophilic asthma.
由: Gunsoy, N, et al.
出版: (2017)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
由: Steven W. Yancey, et al.
出版: (2019-09-01)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
由: Howell, I, et al.
出版: (2024)

Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.
由: Bel, E, et al.
出版: (2014)

Mepolizumab treatment in patients with severe eosinophilic asthma.
由: Ortega, H, et al.
出版: (2014)

Glucocorticoids and mepolizumab in eosinophilic asthma.
由: Bel, E, et al.
出版: (2014)

Mepolizumab in refractory eosinophilic asthma.
由: Pavord, I, et al.
出版: (2010)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
由: Imran Howell, et al.
出版: (2024-07-01)

Mepolizumab for eosinophilic COPD
由: Sciurba, F, et al.
出版: (2018)

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
由: Price, D, et al.
出版: (2019)

Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma
由: Yancey, S, et al.
出版: (2016)

Diagnostic possibility of the combination of exhaled nitric oxide and blood eosinophil count for eosinophilic asthma
由: Jiang-Hua Li, et al.
出版: (2021-08-01)

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
由: David B. Price, et al.
出版: (2019-08-01)

Mepolizumab, quality of life, and severe eosinophilic asthma.
由: Pavord, I
出版: (2017)

Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.
由: Ortega, H, et al.
出版: (2016)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
由: Shrimanker, R, et al.
出版: (2017)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
由: Haldar, P, et al.
出版: (2009)

Biomarkers for severe eosinophilic asthma.
由: Yancey, S, et al.
出版: (2017)

Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
由: Moran, AM, et al.
出版: (2020)

Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab
由: Ian D. Pavord, et al.
出版: (2022-05-01)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
由: Shrimanker, R, et al.
出版: (2017)

Targeting the IL-5 pathway in eosinophilic asthma: a comparison of mepolizumab to benralizumab in the reduction of peripheral eosinophil counts
由: Arian Ghassemian, et al.
出版: (2021-01-01)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
由: Shrimanker, R, et al.
出版: (2017)

Mepolizumab for eosinophilic chronic obstructive pulmonary disease
由: Pavord, I, et al.
出版: (2017)

Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma
由: Jie Gao, et al.
出版: (2018-05-01)

Efficacy and safety of mepolizumab in Japanese patients with severe eosinophilic asthma
由: Terufumi Shimoda, et al.
出版: (2017-07-01)

Does a composite score combining peripheral blood eosinophils (PBE) and exhaled nitric oxide (FeNO) accurately predict a sputum eosinophilia?
由: Connolly, CM, et al.
出版: (2017)

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.
由: Pavord, I, et al.
出版: (2012)

Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes
由: Prazma CM, et al.
出版: (2021-06-01)

Both fractional exhaled nitric oxide and sputum eosinophil were associated with uncontrolled asthma
由: Gao J, et al.
出版: (2018-04-01)

Clinical usefulness of mepolizumab in severe eosinophilic asthma
由: Menzella F, et al.
出版: (2016-06-01)

Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
由: Pavord, I, et al.
出版: (2017)

Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis
由: Charlene M. Prazma, et al.
出版: (2019-05-01)

Blood eosinophil phenotype during treatment with mepolizumab in patients with severe eosinophilic asthma
由: Chio Sakai, et al.
出版: (2024-07-01)

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.
由: Berry, M, et al.
出版: (2005)

Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis
由: Wechsler, M, et al.
出版: (2017)

Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis
由: Buendía, JA, et al.
出版: (2022)

Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis
由: Jefferson Antonio Buendía, et al.
出版: (2022-06-01)

Treatment Resistance in Severe Asthma Patients With a Combination of High Fraction of Exhaled Nitric Oxide and Low Blood Eosinophil Counts
由: Yuki Hoshino, et al.
出版: (2022-04-01)